ArticleENDOSCOPIC VITREORETINAL SURGERY FOR COMPLICATED PROLIFERATIVE DIABETIC RETINOPATHYCIARDELLA, ANTONIO P. MD; FISHER, YALE L. MD; CARVALHO, CLAUDIO MD; SLAKTER, JASON S. MD; BRYAN, RICHARD G. MD, PhD; SORENSON, JOHN A. MD; SPAIDE, RICHARD F. MD; FREUND, K. Bailey MD; GUYER, DAVID R. MD; YANNUZZI, LAWRENCE A. MDAuthor Information *Manhattan Eye, Ear & Throat Hospital, New York; †New York Hospital, Cornell University, New York; and ‡Doheny Eye Institute, University of Southern California, Los Angeles. Reprint requests: Yale L. Fisher, MD, 519 72nd Street, New York, NY 10021. Supported by The LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear & Throat Hospital, New York. No author has a proprietary interest in any of the instruments or techniques described in this paper. Partially presented at the American Academy of Ophthalmology annual meeting; Orlando, Florida; October 25, 1999. Retina: February 2001 - Volume 21 - Issue 1 - p 20-27 Buy Abstract Purpose To evaluate the indication for endoscopic vitreoretinal surgery in proliferative diabetic retinopathy (PDR). Methods Chart review of consecutive cases of vitreoretinal surgery for PDR performed by one of the authors (Y.L.F.) over a 2-year period. Results Endoscopic vitreoretinal surgery was performed in 8 of 41 (19.5%) eyes. The surgical indications were small pupil (3), hyphema (3), pseudophakia with fibrotic posterior capsule (1), and pars plana neovascularization with anterior tractional retinal detachment (6). Conclusion Endoscopic vitreoretinal surgery, by enhancing the visualization of the retroirideal space, is a useful technique in PDR with opaque ocular media and/or neovascularization of the pars plana and ciliary body. © 2001 by Ophthalmic Communications Society, Inc.